
The new study, published on Tuesday in the journal Cell Reports Medicine, examined whether a single dose would achieve greater public health benefit than two doses by allowing protection of a larger population more quickly.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3edleqX
via
IFTTT
0 comments:
Post a Comment